Conference Coverage: SABCS 2021 – Focus on Breast Cancer
Expert perspectives and strategic insights on the latest therapeutic developments in breast cancer treatment.
December 14, 2021
FACULTY CHAIR
Adam Brufsky, MD, PhD
UPMC Hillman Cancer Center, Pittsburgh, PA, US
Faculty Members
Miguel Martin, MD, PhD
Complutense University, Madrid, Spain
Javier Cortes, MD, PhD
Vall d’Hebron University Hospital, Barcelona, Spain
Joyce A. O’Shaughnessy, MD
Texas Oncology-Baylor Charles A. Sammons Cancer Center, Dallas, TX, US
Mark Pegram, MD
Stanford Cancer Institute, CA, US
Hope Rugo, MD, FASCO
UCSF Helen Diller Family Comprehensive Cancer Center, CA, US
Mary Cianfrocca, DO, MBA
City of Hope, Duarte, CA, US
REPORT SNAPSHOT
The report was based on the following topics
- Advancing Therapy for Metastatic HER2+ Breast Cancer
- Other Novel Endocrine Strategies for ER+ Breast Cancer
- ER+ Breast Cancer – Targeting CDKs
- Targeting Triple-Negative Breast Cancer
- Biomarkers and Tailored Therapy
- Other Novel Therapeutic Approaches for Breast Cancer
